Literature DB >> 11989530

The performance of direct agglutination tests (DAT) in the diagnosis of visceral leishmaniasis among Ethiopian patients with HIV co-infection.

A Hailu1, N Berhe.   

Abstract

The incidence of visceral leishmaniasis (VL) in Ethiopia has dramatically increased over the last 10 years, coinciding with the advent of the HIV epidemic. HIV co-infection in VL patients results in atypical, clinical and serological presentations, and may hamper serological diagnosis of VL. The performance of direct agglutination tests (DAT) in the diagnosis of VL in 103 Ethiopian patients with or without HIV infection was therefore investigated. The DAT results indicated that 96 of the patients had leishmanial infections, although amastigotes were only detected in samples from 91. Data on HIV status showed that 50.7% of all patients but 56.0% of the parasitologically confirmed cases of VL patients were HIV-positive. Based on the 95 patients who were each examined both by DAT and parasitological methods, the overall sensitivity of the DAT was 97.7%. Among the parasitologically confirmed cases of VL, a false-negative DAT result was obtained for two (3.9%) of the 51 cases who had HIV co-infection and for none of the 40 HIV-negative cases. In contrast to the observations made in Europe, DAT in Ethiopia therefore remain reasonably sensitive in the diagnosis of VL during HIV co-infection. The results are discussed in view of the possibility of distinctive antibody responses induced by Leishmania donovani donovani and L. d. infantum in HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11989530     DOI: 10.1179/000349802125000475

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  9 in total

1.  Simplified molecular detection of Leishmania parasites in various clinical samples from patients with leishmaniasis.

Authors:  Claire M Mugasa; Thierry Laurent; Gerard J Schoone; Frank L Basiye; Alfarazdeg A Saad; Sayda El Safi; Piet A Kager; Henk Dfh Schallig
Journal:  Parasit Vectors       Date:  2010-03-02       Impact factor: 3.876

2.  Human immunodeficiency virus and leishmaniasis.

Authors:  Navid Ezra; Maria Teresa Ochoa; Noah Craft
Journal:  J Glob Infect Dis       Date:  2010-09

Review 3.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 4.  The diagnostic accuracy of serologic and molecular methods for detecting visceral leishmaniasis in HIV infected patients: meta-analysis.

Authors:  Gláucia Fernandes Cota; Marcos Roberto de Sousa; Fábio Nogueira Demarqui; Ana Rabello
Journal:  PLoS Negl Trop Dis       Date:  2012-05-29

Review 5.  Visceral leishmaniasis and HIV coinfection in the Mediterranean region.

Authors:  Begoña Monge-Maillo; Francesca F Norman; Israel Cruz; Jorge Alvar; Rogelio López-Vélez
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

6.  Validation of rK39 immunochromatographic test and direct agglutination test for the diagnosis of Mediterranean visceral leishmaniasis in Spain.

Authors:  Mathieu Bangert; María D Flores-Chávez; Ivonne P Llanes-Acevedo; Carolina Arcones; Carmen Chicharro; Emilia García; Sheila Ortega; Javier Nieto; Israel Cruz
Journal:  PLoS Negl Trop Dis       Date:  2018-03-01

7.  Epidemiology of visceral leishmaniasis in Shebelle Zone of Somali Region, eastern Ethiopia.

Authors:  Getachew Alebie; Amha Worku; Siele Yohannes; Befikadu Urga; Asrat Hailu; Dagimawie Tadesse
Journal:  Parasit Vectors       Date:  2019-05-06       Impact factor: 3.876

Review 8.  Visceral Leishmaniasis and HIV coinfection in East Africa.

Authors:  Ermias Diro; Lutgarde Lynen; Koert Ritmeijer; Marleen Boelaert; Asrat Hailu; Johan van Griensven
Journal:  PLoS Negl Trop Dis       Date:  2014-06-26

9.  Molecular Tracking of the Leishmania Parasite.

Authors:  Srija Moulik; Shilpa Sengupta; Mitali Chatterjee
Journal:  Front Cell Infect Microbiol       Date:  2021-02-22       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.